CTXR logo

CTXR Citius Pharmaceuticals, Inc.

NASDAQ Capital Market · Biotechnology · Healthcare

$0.51
+0.01 (+2.27%)

Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. Mino-Wrap: A novel liquifying gel-based wrap aimed at minimizin…

Market Cap: $13.96Mwww.citiuspharma.com

Price

No data yet.

Social Signal Score

50
5d
—
30d
50
1 mentions
—
60d
50
2 mentions
—
90d
50
2 mentions
—
news: 2

Analyst Ratings

6 analysts
Buyconsensus
Strong Buy 0Buy 5Hold 1Sell 0Strong Sell 0

Revenue

$1.49M
$0.00$1.31M$2.63M$3.94M
Sep 2016Jun 2026

Analyst Estimates

FY2025
$-2.96
$-2.96–$-2.96
1 analysts
FY2026
$-2.03
$-2.03–$-2.03
1 analysts
FY2027
$-1.44
$-1.44–$-1.44
1 analysts

Consensus estimates, not results. Via Financial Modeling Prep.

Company Profile

CEO
Leonard L. Mazur
Sector
Healthcare
Industry
Biotechnology
Employees
23
Beta
1.04
Country
US
Piotroski score
3 / 9 (Weak)
Altman Z-score
-4.04
www.citiuspharma.com